The frequency of selected polymorphic variants of the RET gene in patients with medullary thyroid carcinoma and in the general population of central Poland

Endocrine Pathology

Volumn 21, Issue 3, 2010, Pages 178-185

  Sromek, Maria ^a   Czetwertyńska, Malgorzata ^a   Skasko, Elzbieta ^a   Zielińska, Joanna ^b   Czapczak, Dorota ^a   Steffen, Jan ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

mRNA sequence; Mutation of the RET gene; Single nucleotide polymorphisms; Sporadic medullary thyroid carcinoma

Indexed keywords

GENOMIC DNA; PROTEIN TYROSINE KINASE;

AGE; ARTICLE; CANCER SUSCEPTIBILITY; CODON; CONTROLLED STUDY; GENE MUTATION; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; POLAND; PRIORITY JOURNAL; PROTO ONCOGENE; RET GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; THYROID MEDULLARY CARCINOMA;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CARCINOMA, MEDULLARY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MUTATION; POLAND; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-RET; THYROID NEOPLASMS; YOUNG ADULT;

EID: 77956472771     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12022-010-9125-8     Document Type: Article

References (34)

1. M Takahashi J Ritz GM Cooper 1985 Activation of the novel human transforming gene RET by DNA rearrangement Cell 42 581 588 10.1016/0092-8674(85) 90115-1 1:CAS:528:DyaL2MXlsFGhs74%3D 2992805
2. M Takahashi Y Buma T Iwamoto Y Inaguma H Ikeda H Hiai 1988 Cloning and expression of the ret proto-oncogene encoding a receptor tyrosine kinase with two potential transmembrane domains Oncogene 3 5 571 578 1:CAS:528: DyaL1MXlt1Oqsbs%3D 3078962
3. S Manie M Santoro A Fusco M Billaud 2001 The ret receptor: function in development and dysfunction in congenital malformation Trends Genet 17 10 580 589 10.1016/S0168-9525(01)02420-9 1:CAS:528:DC%2BD3MXnt1Wju7s%3D 11585664 (Pubitemid 32918300)
4. Y Kodama N Asai K Kawai M Jijiwa Y Murakumo M Ichihara 2005 The RET proto-oncogene: a molecular therapeutic target in thyroid cancer Cancer Sci 96 3 143 148 10.1111/j.1349-7006.2005.00023.x 1:CAS:528:DC%2BD2MXjsFWgt7s%3D 15771616 (Pubitemid 40575914)
5. JWB de Groot TP Links JTM Plukker CJM Lips RMW Hofstra 2006 RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors Endocr Rev 27 5 535 560 10.1210/er.2006-0017 16849421 (Pubitemid 44213230)
6. Z Paszko M Sromek M Czetwertyńska E Skasko D Czapczak A Wisniewska, et al. 2007 The occurrence and the type of germline mutations in the RET gene in patients with medullary thyroid carcinoma and their unaffected kindred's from Central Poland Cancer Invest 25 8 742 749 10.1080/ 07357900701518735 1:CAS:528:DC%2BD2sXhtl2isrvP 18058472 (Pubitemid 350223181)
7. E Arighi MG Borrello M Sariola 2005 RET tyrosine kinase signaling in development and cancer Cytokine Growth Factor Rev 16 441 467 10.1016/j.cytogfr.2005.05.010 1:CAS:528:DC%2BD2MXmvVCnu7s%3D 15982921 (Pubitemid 41022013)
8. BAJ Ponder 1999 The phenotypes associated with ret mutations in the multiple endocrine neoplasia type 2 syndrome Cancer Res (Suppl) 59 1736 1742
9. JR Hansford LM Mulligan 2000 Multiple endocrine neoplasia type 2 and RET from neoplasia to neurogenesis J Med Genet 37 817 827 10.1136/jmg.37.11.817 1:CAS:528:DC%2BD3cXos1Oktb8%3D 11073534
10. Human Genome Project Information: September 19, 2008. http://www.ornl.gov/sci/techresources/Human-Genome/faq/snps.shtml
11. W Gartner I Mineva T Daneva S Baumgartner-Parzer B Niederle H Vierhapper, et al. 2005 A newly identified RET proto-oncogene polymorphism is found in a high number of endocrine tumor patients Hum Genet 117 143 153 10.1007/s00439-005-1280-5 1:CAS:528:DC%2BD2MXltlCis78%3D 15841388 (Pubitemid 43136790)
12. SM Baumgartner-Parzer R Lang L Wagner G Heinze K Niederle K Kaserer, et al. 2005 Polymorphisms in exon 13 and intron 14 of the RET proto-oncogene: genetic modifiers of medullary thyroid carcinoma? J Clin Endocrinol Metab 90 11 6232 6236 10.1210/jc.2005-1278 1:CAS:528:DC%2BD2MXht1altL7L 16118333 (Pubitemid 41606549)
13. R Elisei B Cosci C Romei V Bottici M Sculli R Lari, et al. 2004 RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population J Clin Endocrinol Metab 89 7 3579 3584 10.1210/jc.2003-031898 1:CAS:528:DC%2BD2cXlslegtLc%3D 15240649 (Pubitemid 38951937)
14. IL Hofacker W Fontana PF Stadle LS Bonhoeffer M Tacker P Schuster 1994 Fast folding and comparison of RNA secondary structures Monatsh Chem 125 167 188 10.1007/BF00818163 1:CAS:528:DyaK2cXivFaht7k%3D
15. K Darty A Denise Y Ponty 2009 VARNA: interactive drawing and editing of the RNA secondary structure Bioinformatics 25 15 1974 1975 10.1093/ bioinformatics/btp250 1:CAS:528:DC%2BD1MXovVekur8%3D 19398448
16. L Betts LL Spremulli 1994 Analysis of the role of the Shine-Dalgarno sequence and mRNA secondary structure on the efficiency of translational initiation in the Euglena gracilis chloroplast atpH mRNA J Biol Chem 269 26456 26463 1:CAS:528:DyaK2cXmt1Cnsr4%3D 7929367
17. I Berard JL Kraimps F Savagner A Murat K Renaudin P Nicolli-Sire, et al. 2004 Germline-sequence variants S836S and L769L in the REarranged during Transfection (RET) proto-oncogene are not associated with predisposition to sporadic medullary carcinoma in the French population Clin Genet 65 2 150 152 10.1111/j.0009-9163.2004.00172.x 1:STN:280:DC%2BD2c%2FpsFWrug%3D%3D 14984475 (Pubitemid 38220117)
18. P Costa R Domingues LG Sobrinho MJ Bugalho 2005 RET polymorphisms and sporadic medullary thyroid carcinoma in Portuguese population Endocrine 27 3 239 243 10.1385/ENDO:27:3:239 1:CAS:528:DC%2BD2MXhtFGjurfP 16230779 (Pubitemid 41456739)
19. RM Fernandez E Navarro G Antinolo M Ruiz-Ferrer S Borrego 2006 Evaluation of the role RET polymorphisms/haplotypes as modifier loci for MEN2, and analysis of the correlation with the type of RET mutation in a series of Spanish patients Int J Mol Med 17 4 575 581 1:CAS:528:DC%2BD28XjsVyisLs%3D 16525712
20. Gursoy A, Erdogan MF, Erdogan G. Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients. J Endocrinol Invest 29(10):858-62, 2006.
21. GN Wohllk CE Soto AM Bravo P Becker 2005 G691S, L769L and S836S ret proto-oncogene polymorphisms are not associated with higher risk to sporadic medullary thyroid carcinoma in Chilean patients Rev Med Chile 133 4 397 402
22. M Wiench J Włoch Z Wygoda E Gubala M Oczko A Pawlaczek, et al. 2004 RET polymorphisms in codons 769 and 836 are not associated with predisposition to medullary thyroid carcinoma Cancer Detect Prev 28 231 236 10.1016/j.cdp.2004.04.002 1:CAS:528:DC%2BD2cXovFOlu7w%3D 15350625 (Pubitemid 40125372)
23. A Weinhaeusel C Scheuba M Lauss A Kriegner K Kaserer K Vierlinger OA Haas B Niederle 2008 The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma Thyroid 18 12 1269 1276 10.1089/thy.2008.0139 1:CAS:528:DC%2BD1cXhsVyitbvE 18976163
24. H Vierhapper S Rondot E Schulze L Wagner S Hanslik B Niederle, et al. 2005 Primary hyperparathyroidism as the leading symptom in a patent with a Y791F RET mutation Thyroid 15 11 1303 1308 10.1089/thy.2005.15.1303 1:CAS:528:DC%2BD2MXhtlSqu7fP 16356097 (Pubitemid 41821766)
25. A Patocs Z Valkusz P Igaz K Balogh M Toth I Varga, et al. 2003 Segregation of the V804L mutation and S836S polymorphisms of exon 14 of the RET gene in an extended kindred with familial medullary thyroid cancer Clin Genet 63 3 219 223 10.1034/j.1399-0004.2003.00044.x 1:STN:280:DC%2BD3s7ns1eqsA%3D%3D 12694233 (Pubitemid 36949924)
26. S Borrego ME Saez A Ruiz K Balogh M Toth I Varga, et al. 1999 Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression J Med Genet 36 10 771 774 1:CAS:528:DyaK1MXntVWnsrs%3D 10528857
27. O Gimm DS Neuberg DJ Marsh PLM Dahia C Hoang-Vu F Raue, et al. 1999 Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation Oncogene 18 1369 1373 10.1038/sj.onc.1202418 1:CAS:528:DyaK1MXhsFaqtbg%3D 10022819
28. A Ruiz G Antinolo RM Fernandez C Eng I Marcos S Borrego 2001 Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population Clin Endocrinol 55 3 399 402 10.1046/j.1365-2265.2001.01328.x 1:CAS:528:DC%2BD3MXnslKrtbs%3D (Pubitemid 32823050)
29. P Griseri M Sancandi G Patrone R Bocciardi R Hofstra R Ravazzolo, et al. 2000 A single-nucleotide polymorphic variant of the RET proto-oncogene is underrepresented in sporadic Hirschsprung disease Eur J Hum Genet 8 721 724 10.1038/sj.ejhg.5200521 1:CAS:528:DC%2BD3cXntFOmtbc%3D 10980580
30. M Robledo L Gil M Pollan A Cebrian S Ruiz M Azanedo J Benitez J Menarguez JM Rojas 2003 Polymorphisms G691S/S904S of RET as genetic modifiers of MEN2A Cancer Res 63 1814 1817 1:CAS:528:DC%2BD3sXivFyns70%3D 12702567
31. JL Parmley LD Hurt 2007 How do synonymous mutations affect fitness? Bioassay 29 6 515 519 10.1002/bies.20592 1:CAS:528:DC%2BD2sXntVCmur4%3D (Pubitemid 46903939)
32. C Kimchi-Sarfaty JM Oh IW Kim ZE Sauna AM Calcagno SV Ambudkar, et al. 2007 A "silent" polymorphisms in the MDR1 gene changes substrate specificity Science 26 525 528 10.1126/science.1135308 (Pubitemid 46175758)
33. V Muñoz PA Thompson J Hofrichter WA Eaton 1997 Folding dynamics and mechanism of β-hairpin formation Nature 390 196 199 10.1038/36626 9367160 (Pubitemid 27507992)
34. Y Nakamura T Gojobori T Ikemura 2007 Codon usage tabulated from the international DNA sequence databases Nucleic Acids Res 26 1 334 10.1093/nar/26.1.334